The utility of fractional exhaled nitric oxide suppression in the identification of nonadherence in difficult asthma

American Journal of Respiratory and Critical Care Medicine

Volumn 186, Issue 11, 2012, Pages 1102-1108

  McNicholl, Diarmuid M ^a   Stevenson, Michael ^a   McGarvey, Lorcan P ^a   Heaney, Liam G ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

Asthma; Exhaled nitric oxide; Nonadherence

Indexed keywords

BUDESONIDE; OMALIZUMAB; PREDNISOLONE; TRIAMCINOLONE;

ADULT; ARTICLE; ASTHMA; CLINICAL ARTICLE; CLINICAL ASSESSMENT TOOL; DIRECTLY OBSERVED INHALED CORTICOSTEROID; DIRECTLY OBSERVED THERAPY; FEMALE; FORCED EXPIRATORY VOLUME; FRACTIONAL EXHALED NITRIC OXIDE; HUMAN; MALE; PATIENT COMPLIANCE; PREDICTIVE VALUE; PRESCRIPTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY;

ADMINISTRATION, INHALATION; ADRENAL CORTEX HORMONES; ADULT; ASTHMA; BREATH TESTS; BRONCHODILATOR AGENTS; DRUG ADMINISTRATION SCHEDULE; EXHALATION; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; NITRIC OXIDE; PATIENT COMPLIANCE; PREDNISOLONE; PROSPECTIVE STUDIES; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS; RESPIRATORY FUNCTION TESTS; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 84870446529     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201204-0587OC     Document Type: Article

References (46)

1. Global Initiative for Asthma (GINA). Global strategy for asthma management and prevention. 2011. Available from: http://www.ginasthma.org/.
2. Robinson DS, Campbell DA, Durham SR, Pfeffer J, Barnes PJ, Chung KF. Systematic assessment of difficult-to-treat asthma. Eur Respir J 2003;22:478-483.
3. Araujo AC, Ferraz E, Borges Mde C, Filho JT, Vianna EO. Investigation of factors associated with difficult-to-control asthma. J Bras Pneumol 2007;33:495-501.
4. Heaney LG, Conway E, Kelly C, Johnston BT, English C, Stevenson M, Gamble J. Predictors of therapy resistant asthma: outcome of a systematic evaluation protocol. Thorax 2003;58:561-566.
5. Murphy AC, Proeschel A, Brightling CE, Wardlaw AJ, Pavord ID, Bradding P, Green RH. The relationship between clinical outcomes and medication adherence in difficult-to-control asthma. Thorax 2012;67:751-753.
6. Gamble J, Stevenson M, McClean E, Heaney LG. The prevalence of nonadherence in difficult asthma. Am J Respir Crit Care Med 2009;180:817-822.
7. Dweik RA, Boggs PB, Erzurum SC, Irvin CG, Leigh MW, Lundberg JO, Olin AC, Plummer AL, Taylor DR. An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FeNO) for clinical applications. Am J Respir Crit Care Med 2011;184:602-615.
8. Taylor DR, Pijnenburg MW, Smith AD, De Jongste JC. Exhaled nitric oxide measurements: clinical application and interpretation. Thorax 2006;61:817-827.
9. Gustafsson LE, Leone AM, Persson MG, Wiklund NP, Moncada S. Endogenous nitric oxide is present in the exhaled air of rabbits, guinea pigs and humans. Biochem Biophys Res Commun 1991;181:852-857.
10. Jatakanon A, Lim S, Kharitonov SA, Chung KF, Barnes PJ. Correlation between exhaled nitric oxide, sputum eosinophils, and methacholine responsiveness in patients with mild asthma. Thorax 1998;53:91-95.
11. Payne DN, Adcock IM, Wilson NM, Oates T, Scallan M, Bush A. Relationship between exhaled nitric oxide and mucosal eosinophilic inflammation in children with difficult asthma, after treatment with oral prednisolone. Am J Respir Crit Care Med 2001;164:1376-1381.
12. Kharitonov SA, Donnelly LE, Montuschi P, Corradi M, Collins JV, Barnes PJ. Dose-dependent onset and cessation of action of inhaled budesonide on exhaled nitric oxide and symptoms in mild asthma. Thorax 2002;57:889-896.
13. Smith AD, Cowan JO, Brassett KP, Filsell S, McLachlan C, Monti-Sheehan G, Peter Herbison G, Robin Taylor D. Exhaled nitric oxide: a predictor of steroid response. Am J Respir Crit Care Med 2005;172:453-459.
14. Silkoff PE, Lent AM, Busacker AA, Katial RK, Balzar S, Strand M, Wenzel SE. Exhaled nitric oxide identifies the persistent eosinophilic phenotype in severe refractory asthma. J Allergy Clin Immunol 2005;116:1249-1255.
15. Perez-de-Llano LA, Carballada F, Castro Anon O, Pizarro M, Golpe R, Baloira A, Vazquez Caruncho M, Boquete M. Exhaled nitric oxide predicts control in patients with difficult-to-treat asthma. Eur Respir J 2010;35:1221-1227.
16. Petsky HL, Cates CJ, Lasserson TJ, Li AM, Turner C, Kynaston JA, Chang AB. A systematic review and meta-analysis: tailoring asthma treatment on eosinophilic markers (exhaled nitric oxide or sputum eosinophils). Thorax 2012;67:199-208.
17. Powell H, Murphy VE, Taylor DR, Hensley MJ, McCaffery K, Giles W, Clifton VL, Gibson PG. Management of asthma in pregnancy guided by measurement of fraction of exhaled nitric oxide: a double-blind, randomised controlled trial. Lancet 2011;378:983-990.
18. Beck-Ripp J, Griese M, Arenz S, Koring C, Pasqualoni B, Bufler P. Changes of exhaled nitric oxide during steroid treatment of childhood asthma. Eur Respir J 2002;19:1015-1019.
19. Delgado-Corcoran C, Kissoon N, Murphy SP, Duckworth LJ. Exhaled nitric oxide reflects asthma severity and asthma control. Pediatr Crit Care Med 2004;5:48-52.
20. McNicholl DM, Stevenson M, McGarvey LP, Heaney LG. The use of fractional exhaled nitric oxide in the identification of non-adherence in difficult asthma. Presented at the American Thoracic Society 2010 International Conference. May 14-19, 2010, New Orleans, LA. A3811.
21. McNicholl DM, Stevenson M, McGarvey LP, Heaney LG. Developing and validating a FeNO suppression test identifying non-adherence in difficult asthma. Presented at the American Thoracic Society International Conference 2011. May 13-18, 2011, Denver, CO. A4379.
22. McNicholl DM, McGarvey LP, Heaney LG. Is a high FeNO a marker of non-adherence in difficult asthma? Presented at the British Thoracic Society Winter Meeting 2011. Dec 7-9, 2011, London, UK. A8.
23. American Thoracic Society, European Respiratory Society. ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005. Am J Respir Crit Care Med 2005;171:912-930.
24. Paggiaro PL, Chanez P, Holz O, Ind P, Djukanovic R, Maestrelli P, Sterk P. Sputum induction. Eur Respir J 2002;20:3s-8s.
25. Efthimiadis A, Spanevello A, Hamid Q, Kelly MM, Linden M, Louis R, Pizzichini MM, Pizzichini E, Ronchi C, Van Overvel F, et al. Methods of sputum processing for cell counts, immunocytochemistry and in situ hybridisation. Eur Respir J Suppl 2002;37:19s-23s.
26. Juniper EF, O'Byrne PM, Guyatt GH, Ferrie PJ, King DR. Development and validation of a questionnaire to measure asthma control. Eur Respir J 1999;14:902-907.
27. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, van der Grinten CP, Gustafsson P, et al. Standardisation of spirometry. Eur Respir J 2005;26:319-338.
28. Cano-Garcinuno A, Carvajal-Uruena I, Diaz-Vazquez CA, Dominguez-Aurrecoechea B, Garcia-Merino A, de Rodas PM, Mora-Gandarillas I. Clinical correlates and determinants of airway inflammation in pediatric asthma. J Investig Allergol Clin Immunol 2010;20:303-310.
29. Katsara M, Donnelly D, Iqbal S, Elliott T, Everard ML. Relationship between exhaled nitric oxide levels and compliance with inhaled corticosteroids in asthmatic children. Respir Med 2006;100:1512-1517.
30. Heaney LG, Brightling CE, Menzies-Gow A, Stevenson M, Niven RM. Refractory asthma in the UK: cross-sectional findings from a UK multicentre registry. Thorax 2010;65:787-794.
31. Dweik RA, Sorkness RL, Wenzel S, Hammel J, Curran-Everett D, Comhair SA, Bleecker E, Busse W, Calhoun WJ, Castro M, et al. Use of exhaled nitric oxide measurement to identify a reactive, at-risk phenotype among patients with asthma. Am J Respir Crit Care Med 2010;181:1033-1041.
32. Zeiger RS, Schatz M, Zhang F, Crawford WW, Kaplan MS, Roth RM, Chen W. Association of exhaled nitric oxide to asthma burden in asthmatics on inhaled corticosteroids. J Asthma 2011;48:8-17.
33. Panickar JR, Bhatnagar N, Grigg J. Exhaled nitric oxide after a single dose of intramuscular triamcinolone in children with difficult to control asthma. Pediatr Pulmonol 2007;42:573-578.
34. ten Brinke A, Zwinderman AH, Sterk PJ, Rabe KF, Bel EH. "Refractory" eosinophilic airway inflammation in severe asthma: effect of parenteral corticosteroids. Am J Respir Crit Care Med 2004;170:601-605.
35. Radomski MW, Palmer RM, Moncada S. Glucocorticoids inhibit the expression of an inducible, but not the constitutive, nitric oxide synthase in vascular endothelial cells. Proc Natl Acad Sci USA 1990;87:10043-10047.
36. Barnes PJ, Dweik RA, Gelb AF, Gibson PG, George SC, Grasemann H, Pavord ID, Ratjen F, Silkoff PE, Taylor DR, et al. Exhaled nitric oxide in pulmonary diseases: a comprehensive review. Chest 2010;138:682-692.
37. Buchvald F, Eiberg H, Bisgaard H. Heterogeneity of FeNO response to inhaled steroid in asthmatic children. Clin Exp Allergy 2003;33:1735-1740.
38. Kelloway JS, Wyatt RA, Adlis SA. Comparison of patients' compliance with prescribed oral and inhaled asthma medications. Arch Intern Med 1994;154:1349-1352.
39. Hansen RA, Kim MM, Song L, Tu W, Wu J, Murray MD. Comparison of methods to assess medication adherence and classify nonadherence. Ann Pharmacother 2009;43:413-422.
40. Smith A, Krishnan JA, Bilderback A, Riekert KA, Rand CS, Bartlett SJ. Depressive symptoms and adherence to asthma therapy after hospital discharge. Chest 2006;130:1034-1038.
41. Williams LK, Joseph CL, Peterson EL, Moon C, Xi H, Krajenta R, Johnson R, Wells K, Booza JC, Tunceli K, et al. Race-ethnicity, crime, and other factors associated with adherence to inhaled corticosteroids. J Allergy Clin Immunol 2007;119:168-175.
42. Williams LK, Joseph CL, Peterson EL, Wells K, Wang M, Chowdhry VK, Walsh M, Campbell J, Rand CS, Apter AJ, et al. Patients with asthma who do not fill their inhaled corticosteroids: a study of primary nonadherence. J Allergy Clin Immunol 2007;120:1153-1159.
43. Chatkin JM, Cavalet-Blanco D, Scaglia NC, Tonietto RG, Wagner MB, Fritscher CC. Compliance with maintenance treatment of asthma (ADERE study). J Bras Pneumol 2006;32:277-283.
44. Naleway AL, Vollmer WM, Frazier EA, O'Connor E, Magid DJ. Gender differences in asthma management and quality of life. J Asthma 2006;43:549-552.
45. Krigsman K, Moen J, Nilsson JL, Ring L. Refill adherence by the elderly for asthma/chronic obstructive pulmonary disease drugs dispensed over a 10-year period. J Clin Pharm Ther 2007;32:603-611.
46. Corsico AG, Cazzoletti L, de Marco R, Janson C, Jarvis D, Zoia MC, Bugiani M, Accordini S, Villani S, Marinoni A, et al. Factors affecting adherence to asthma treatment in an international cohort of young and middle-aged adults. Respir Med 2007;101:1363-1367.